000 | 01969 a2200481 4500 | ||
---|---|---|---|
005 | 20250517105916.0 | ||
264 | 0 | _c20170912 | |
008 | 201709s 0 0 eng d | ||
022 | _a1527-7755 | ||
024 | 7 |
_a10.1200/JCO.2015.61.8983 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShah, Mithun Vinod | |
245 | 0 | 0 |
_aChange in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists Guidelines. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _c10 2016 |
||
300 |
_a3502-3510 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aBreast Neoplasms _xchemistry |
650 | 0 | 4 | _aFalse Negative Reactions |
650 | 0 | 4 | _aFalse Positive Reactions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aIn Situ Hybridization, Fluorescence _xmethods |
650 | 0 | 4 | _aMedical Oncology |
650 | 0 | 4 | _aNucleic Acid Amplification Techniques |
650 | 0 | 4 | _aPathology |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xanalysis |
650 | 0 | 4 | _aSocieties, Medical |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
700 | 1 | _aWiktor, Anne E | |
700 | 1 | _aMeyer, Reid G | |
700 | 1 | _aTenner, Kathleen S | |
700 | 1 | _aBallman, Karla V | |
700 | 1 | _aGreen, Stefan J | |
700 | 1 | _aSukov, William R | |
700 | 1 | _aKetterling, Rhett P | |
700 | 1 | _aPerez, Edith A | |
700 | 1 | _aJenkins, Robert B | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 34 _gno. 29 _gp. 3502-3510 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2015.61.8983 _zAvailable from publisher's website |
999 |
_c26265908 _d26265908 |